The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.455%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 56.50
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

25 Jun 2019 07:00

RNS Number : 2625D
Accsys Technologies PLC
25 June 2019
 

AIM: AXS

Euronext Amsterdam: AXS

25 June 2019 

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Directorate Change

 

Accsys announces today that as part of succession planning, Paul Clegg will step down as CEO after ten years in the role.

 

Paul joined Accsys as CEO in 2009. Since then the Group has restructured and grown considerably and now has a solid platform as reflected by today's announcement of preliminary financial results for the year ended 31 March 2019. Both Paul and the Board feel that at this important time in the Company's evolution, as it seeks to expand, build and operate wood acetylation plants around the world, it requires a CEO with extensive manufacturing expertise.

 

The Board wishes to express its appreciation for the very important contribution Paul has made to the development of the business throughout his time with Accsys. A search for a new CEO is underway. The Board is grateful that Paul has agreed to stay on as CEO and a Board member, until 31 December 2019, allowing adequate time to complete the search for his successor

 

Patrick Shanley, Chairman, commented "Since Paul joined the Company in 2009 he has overseen a transformation in our strategy, from one of licensing our technology to one focussed on expanding commercial and manufacturing operations in Europe, and more recently targeting growth in North America and Asia. We are grateful for the significant contribution Paul has made to the business and wish him well in his next endeavours."

Paul Clegg said, "I will always remain passionate about Accsys, its amazing products and its hardworking people, however I believe that the next phase in the Company's evolution will benefit from someone with extensive manufacturing expertise, to ensure the Company is able to fully exploit the significant expected increase in its manufacturing capacity around the world.''

 

 

 

 

 

Accsys Technologies PLC("Accsys", de "Groep" of de "Vennootschap")Bestuurswisseling

Accsys kondigt vandaag aan dat Paul Clegg, als onderdeel van succession planning, na tien jaar zal aftreden als CEO.

Paul Clegg werd in 2009 CEO van Accsys. Sindsdien is de Groep geherstuctureerd en heeft zij een aanzienlijke groei doorgemaakt. Accsys heeft nu een solide basis zoals ook blijkt uit de vandaag aangekondigde voorlopige financiële resultaten van het financiële jaar dat eindigde op 31 maart 2019. Zowel Paul als het Bestuur zijn van mening dat op dit belangrijke moment waarbij Accsys inzet op de wereldwijde uitbreiding, bouw en exploitatie van acetylatie-fabrieken voor hout, Accsys een CEO nodig heeft die uitgebreide expertise heeft op het gebied van productie.

Het Bestuur spreekt zijn waardering uit voor de zeer belangrijke bijdrage die Paul heeft geleverd aan de ontwikkeling van de onderneming gedurende zijn tijd bij Accsys. Een zoektocht naar een nieuwe CEO is gestart. Het Bestuur is dankbaar dat Paul heeft ingestemd om aan te blijven als CEO en Bestuurslid tot 31 december 2019, om daarmee voldoende tijd te geven om de zoektocht naar zijn opvolger af te ronden.

Patrick Shanley, Voorzitter van het Bestuur, zei: "Sinds Paul bij de onderneming kwam in 2009 heeft hij leiding gegeven aan een transformatie van de onderneming die was gericht op het licentiëren van onze technologie naar het toeleggen op het uitbreiden van de commerciële en productieactiviteiten in Europa en meer recent ook een uitbreiding van onze activiteiten naar Noord-Amerika en Azië. We zijn dankbaar voor de belangrijke bijdrage die Paul heeft geleverd aan de onderneming en wensen hem het beste voor de toekomst."

Paul Clegg zei: "Ik zal altijd gepassioneerd blijven over Accsys, haar geweldige producten en haar hardwerkende medewerkers, maar ik geloof dat in de volgende fase de onderneming zal profiteren van iemand met uitgebreide expertise op het gebied van productie om ervoor te zorgen dat onderneming in staat is de verwachte toename van de wereldwijde productie van geacetyleerd hout in goede banen te leiden.''

 

Ends

 

For further information, please contact:

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

via MHP Communications

 

Numis Securities - Nominated Adviser and Joint Broker

Nominated Adviser: Oliver Hardy

Corporate Broking: Christopher Wilkinson / Ben Stoop

 

+44 (0) 20 7260 1000

 

 

Investec Bank plc - Joint Broker

Carlton Nelson

James Rudd

Alex Wright

 

 

+44 (0) 20 7597 5970

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

 

 

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derske

 

 

+31 681 734 236

+31 222 379 666

 

Notes to editors:

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Tricoya® Consortium In March 2017, Accsys announced the formation of the Tricoya® Consortium to fund, build and operate the Tricoya® plant in Hull, UK. Members of the consortium include BP and the leading manufacturer of sustainable wood-based panels, MEDITE Europe DAC. Tricoya Ventures UK Ltd (TVUK), a subsidiary of Accsys, owns and will operate the Tricoya® plant. TTL exploits all Tricoya® related intellectual property and benefits from any Tricoya® related revenues other than those generated by the Tricoya® plant. The Tricoya® plant is expected to have an initial capacity of 30,000 metric tonnes of Tricoya® chips per annum, enough to produce approximately 40,000m3 of Tricoya® panel products per annum. The Tricoya® plant is expected to reach EBITDA breakeven at approximately 40% design capacity and to take approximately four years to reach full capacity following completion. The location of the Tricoya® plant at Saltend Chemicals Park in Hull allows for expansion when market conditions dictate.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGZVLDMGLZM
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.